Last quarter (Q ), Global Blood Therapeutics's total revenue was $71.55M, an increase of 50.46% from the same quarter last year. In Q, Global Blood Therapeutics's net income was $-82.47M. See Global Blood Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 234.86M	$ 194.75M	$ 123.80M	$ 2.11M	$ 0.00	$ 0.00
Cost of Revenue	$ 4.45M	$ 3.32M	$ 1.99M	$ 48.00K	$ 0.00	$ 0.00
Gross Profit	$ 230.41M	$ 191.43M	$ 121.82M	$ 2.06M	$ 0.00	$ 0.00
Operating Expense	$ 529.65M	$ 479.12M	$ 365.97M	$ 291.64M	$ 182.74M	$ 119.25M
Operating Income	$ -299.24M	$ -287.69M	$ -244.16M	$ -289.58M	$ -182.74M	$ -119.25M
Net Non Operating Interest Income Expense	$ -22.32M	$ -14.75M	$ -3.98M	$ 14.70M	$ 8.62M	$ 2.56M
Other Income Expense	$ -62.00K	$ -177.00K	$ 578.00K	$ 8.12M	$ -69.00K	$ -334.00K
Pretax Income	$ -321.62M	$ -302.61M	$ -247.55M	$ -266.77M	$ -174.19M	$ -117.02M
Tax Provision	$ 363.00K	$ 477.00K	$ 0.00	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -322.46M	$ -303.09M	$ -247.55M	$ -266.77M	$ -174.19M	$ -117.02M
Basic EPS	$ -5.01	$ -4.81	$ -4.04	$ -4.57	$ -3.41	$ -2.76
Diluted EPS	$ -5.01	$ -4.81	$ -4.04	$ -4.57	$ -3.41	$ -2.76
Basic Average Shares	$ 257.87M	$ 62.96M	$ 61.33M	$ 58.32M	$ 51.15M	$ 42.32M
Diluted Average Shares	$ 257.87M	$ 62.96M	$ 61.33M	$ 58.32M	$ 51.15M	$ 42.32M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 534.10M	$ 482.44M	$ 367.96M	$ 291.69M	$ 182.74M	$ 119.25M
Net Income From Continuing And Discontinued Operation	$ -322.46M	$ -303.09M	$ -247.55M	$ -266.77M	$ -174.19M	$ -117.02M
Normalized Income	$ -322.46M	$ -303.09M	$ -248.54M	$ -275.07M	$ -174.19M	$ -117.02M
Interest Expense	$ 24.71M	$ 15.47M	$ 9.81M	$ 894.00K	$ 346.00K	-
EBIT	$ -296.91M	$ -287.15M	$ -237.74M	$ -265.87M	$ -173.85M	$ -119.25M
EBITDA	$ -287.94M	$ -278.53M	$ -226.92M	$ -255.94M	$ -169.24M	$ -117.59M

Currency in USD

Global Blood Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing